在接受手术的2型糖尿病患者中，比较甘精胰岛素和赖脯胰岛素与地特胰岛素和门冬胰岛素治疗方案实现血糖控制的效果评估。
Evaluation of Glycemia Control Achieved by Glargine and Lispro Versus Detemir and Aspart Insulin Regimes in Type 2 Diabetics Undergoing Surgery.
作者信息
Ahmad Mushtaq, Wafai Z A, Mathur S K, Lodha S, Khan Z Y, Bansal Alka
机构信息
Department of Pharmacology, Punjab Institute of Medical Sciences, Jalandhar.
Department of Clinical Pharmacology, Sheri-I- Kashmir Institute of Medical Sciences, Srinagar.
出版信息
Open Cardiovasc Med J. 2015 Jun 26;9:58-61. doi: 10.2174/1874192401509010058. eCollection 2015.
There is paucity of scientific literature regarding the clinical outcome of long lasting basal insulin and rapid acting mealtime insulin regimes in surgical situations although employed in non-surgical situations. This study has evaluated the clinical outcome of two subcutaneous split-mixed Glargine+Lispro and Detemir+Aspart insulin regimes in type 2 diabetics undergoing surgery.
尽管长效基础胰岛素和速效餐时胰岛素方案在非手术情况下已被采用，但关于其在手术情况下临床结果的科学文献却很匮乏。本研究评估了两种皮下混合注射甘精胰岛素+赖脯胰岛素和地特胰岛素+门冬胰岛素方案在接受手术的2型糖尿病患者中的临床结果。
Zotero 插件